Board Meeting14 Nov 2026, 08:22 pm
Astonea Labs Resubmits Board Meeting Outcome and Financial Results
AI Summary
Astonea Labs Ltd has resubmitted its Board Meeting outcome and financial results originally filed on November 14, 2026. The resubmission is due to inadvertent truncation and improper arrangement of uploaded documents. The Board approved the Unaudited Standalone and Consolidated Financial Results for the Half-Year Ended September 30, 2026, prepared under Ind AS. The company also noted its voluntary adoption of Ind AS from April 1, 2026. Additionally, the Board approved proposed related party transactions with Longevity Science Private Limited, with Astonea Labs proposing to subscribe to 51% of Longevity Science's share capital, making it a subsidiary.
Key Highlights
- Astonea Labs resubmitted board meeting outcome and financial results due to document errors.
- Unaudited standalone and consolidated financial results for H1 FY27 were approved.
- Company voluntarily adopted Indian Accounting Standards (Ind AS) from April 1, 2026.
- Proposed related party transactions with Longevity Science Private Limited approved.
- Astonea Labs plans to subscribe to 51% of Longevity Science's share capital, forming a subsidiary.
Price Impact
More from ASTONEALAB